Skip to main content
. 2005 May 31;92(Suppl 1):S6–S13. doi: 10.1038/sj.bjc.6602603

Figure 2.

Figure 2

ZD6474 inhibits tumour-induced new blood vessel development. A549 tumour cells were implanted intradermally and new blood vessel formation was assessed after 5 days' administration of ZD6474 (50 or 100 mg kg−1 day−1) or vehicle (Wedge et al, 2002).